L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness
Osamu Kaminuma,
Tomoe Nishimura,
Mayumi Saeki,
Norimasa Yamasaki,
Sawako Ogata,
Tomoe Fujita,
Hitoshi Endou,
Keitaro Hayashi
Affiliations
Osamu Kaminuma
Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan; Center for Life Science Research, University of Yamanashi, Yamanashi, Japan; Allergy and Immunology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Tomoe Nishimura
Allergy and Immunology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Mayumi Saeki
Allergy and Immunology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
Norimasa Yamasaki
Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
Sawako Ogata
Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
Tomoe Fujita
Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Japan
Hitoshi Endou
J-Pharma Co., Ltd., Yokohama, Japan
Keitaro Hayashi
Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Japan; Corresponding author. Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan.
